Clinical Trial Update: Thymosin-α1 in Cancer-Related Fatigue [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for thymosin-α1 targeting cancer-related fatigue and quality of life.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer-related Fatigue

Snippet

Sponsor: Zhigang Zhang | Conditions: Cancer Related Fatigue, Quality of Life | Phase 3 | Status: UNKNOWN